LAUREN HOGUE: Open Payments
NPI 1356696918 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 42 payments from 15 companies in 2025. Trend: 2023 $808 · 2024 $630 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $171 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Novo Nordisk Inc | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| PFIZER INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Medtronic, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Corcept Therapeutics | 1 | $27 |
| Exact Sciences Corporation | 1 | $19 |
Products named: VRAYLAR, AIRSUPRA, Ozempic, VOQUEZNA, QULIPTA, UBRELVY, GARDASIL 9, INCEPTIV.
Industry payments across OH — which companies pay providers there.
